New siRNA nanotherapy for inflammatory bowel diseases (targeting Jak1/3)

Understanding immune and microbiological resetting after hematopoietic stem cell transplant in Crohn’s Disease patients

Role of the intestinal epithelial barrier in IBD

Transcriptional analysis of the intestinal mucosa as a tool to understand response or lack of response to therapy

Molecular mechanisms of disease remission

Microbial-specific T-cell responses in Crohn's Disease

Identification of new biomarkers in inflammatory bowel disease